Tag Archives: marijuana

Eric Holder Reigns in DEA Chief Michele Leonhart for Undermining Obama’s Position on Marijuana Sentencing

Left, Michelle Leonhart; right, Eric Holder
Left, Michele Leonhart; right, Eric Holder

In recent talks with Attorney General Eric Holder, DEA Chief Michele Leonhart was encouraged to tone down the Drug War propaganda she has been advancing since the Obama administration did not sue the state of Colorado for legalizing marijuana. Since then, she has taken several public stands against the administration’s rhetoric on marijuana legalization and, more recently, lessening the punishment of people who commit federal drug crimes.

According to Huffington Post’s Ryan Reilly and Ryan Grim, Leonhart was “called in” by Holder for a “one [on] one chat about her recent insubordination.” As a 34-year bureaucrat of the DEA, Leonhart is having a hard time shifting her tone away from the DEA’s aggressive stance against illegal drugs.

Since the talks, Leonhart has said she “supports the Attorney General’s sentencing reform initiative to ensure those sentences are imposed appropriately” through legislation like the Smarter Sentencing Act. This type of legislation would save taxpayers billions of dollars and keep thousands of people out of jail for certain types of nonviolent crimes, like marijuana use, by eliminating mandatory minimum sentencing.

Michele Leonhart’s alignment with the Obama administration’s stance on drug sentencing and marijuana policy creates cautious optimism for change in the prosecution of unnecessary federal arrests.

NY Senate Has the Votes to Pass Medical Marijuana Bill

 

Sen. Diane Savino
Sen. Diane Savino

New York Sen. Diane Savino (D-Staten Island) claims she has rallied enough votes to pass SB 4406, which legalizes medical marijuana. Thirty-nine senators, seven more than what is needed to pass the bill, have pledged their support.

However, gathering this support has come at a price. Three significant changes differentiate the current bill from the original.

First, physicians are limited to recommending medical marijuana for only 20 conditions. Secondly, the bill would create an advisory committee to recommend additions to the list of qualifying conditions. This board could also hear appeals for individual patients who fall outside of the list. Lastly, people under 21 would not be permitted to smoke marijuana as a treatment; they would be restricted to ingesting or vaporizing.

Other details of the bill include required medical marijuana cards for patients, a limit of up to 2.5 ounces per 30-day supply, and the dispensaries would have to pay taxes to the state.

According to the New York Daily News, it looks like the Senate’s Health Committee will take up the bill at noon on Tuesday.

Wisconsin Girl Dies Waiting for Implementation of Cannabis Oil Legislation

Lydia Schaeffer
Lydia Schaeffer

Tragically, Lydia Schaeffer (aged 7) passed away on Mother’s Day from a rare genetic disorder called Kleefstra syndrome, which causes terrible seizures and other complications. Her plight inspired lawmakers in Wisconsin to legalize a marijuana extract to treat her condition, despite their opposition to a broader medical marijuana reform.

Sally Schaeffer, Lydia’s mother, lobbied the state legislature to legalize the cannabidiol (CBD) extract from the marijuana stain known as Charlotte’s Web for use on children with seizure disorders. Even though lawmakers moved to pass the limited CBD-only bill in record time, determining the implications of the law stalled it from going into effect. Additionally, CBD-only bills leave behind 98% of the patients who can benefit from medical marijuana, so Wisconsin still has a long way to go before patients have legal access to this much-needed medicine.

In Lydia’s honor, Sally plans to continue spreading the word on CBD oil. She said she was contacted by Sen. Robert Wirch’s office this week and told they would try to have the bill she championed called Lydia’s Law. Wirch’s sympathy toward the Schaeffer family is welcomed, but his and other politicians’ compassion for the vast majority of other patients in need is currently lacking.

NFL Is Rethinking Its Drug Policy, Reducing Marijuana Punishments

NFLAn inside source told ESPN.com on Tuesday that the NFL is in the process of renegotiating its drug policy and may institute changes specific to how athletes who use marijuana are handled.

Since 2011, the NFL has been internally debating its drug policy, which includes testing for human growth hormones. If the current revisions to the drug policy are approved, the threshold for a positive marijuana test will be significantly increased, and punishments for violating the policy will be reduced.

The delay in these changes to the NFL policy stems from a “continued standoff over arbitration of discipline,” according to ESPN. “In cases of non-analytical positives (i.e., an Alex Rodriguez-type case in which a player is found to be in violation of the drug policy by some method other than a failed test) or in cases of violations of law (i.e., a player getting caught trying to smuggle prescription drugs across the Canadian border), the NFLPA has asked that discipline appeals be heard by an independent arbitrator.”

However, the NFL insists that the commissioner (Roger Goodell) has final say over disciplinary matters. Once this power struggle over the administration of discipline is resolved, the changes to the NFL’s drug policy should go into effect.

Alzheimer’s Prevention Starts with Marijuana, According to British Journal

Alzheimer's Disease includes reduced brain activity and function (red areas above), the result of years of accumulated damage. THC and CBD in marijuana seem to prevent this damage.
Alzheimer’s Disease includes reduced brain activity and function (red areas above), the result of years of accumulated damage. THC and CBD in marijuana seem to prevent this damage.

A paper published by the British Journal of Pharmacology suggests that the chemical compounds in marijuana likely prevent the onset of Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and age-related dementia.

Chronic brain inflammation, oxidative stress, and intra-cellular dysfunction are the primary reasons why people develop these debilitating neurological diseases. The study found that both THC and CBD (the primary chemical compounds found in marijuana) positively affect nerve cell function in consumers, significantly reducing these harmful neurological conditions.

THC and CBD (called cannabinoids) tap into a primal, chemical signaling system in cells called “the endocannabinoid system.” The paper shows cannabinoids dampen inflammation, protect cells from oxidative damage, and promote cell health on a number of levels.

This paper echoes claims made in January by Gary Wenk, professor of neuroscience, immunology, and medical genetics at Ohio State University, that “if you do anything, such as smoke a bunch of marijuana in your 20s and 30s, you may wipe out all of the inflammation in your brain and then things start over again. And you simply die of old age before inflammation becomes an issue for you,”

The implications of marijuana’s medicinal effects on our brains are monumental, from not just a health perspective, but a financial one as well, for more than five million Americans with Alzheimer’s. One in three seniors will die with Alzheimer’s or another form of dementia, and Alzheimer’s is the sixth leading cause of death in the nation, costing the country about $203 billion in 2013.